MFN2 and diabetic kidney disease: Astragaloside II (AS-II) (Su et al., 2021) has been found to improve mitochondrial dynamics by upregulating Mitofusin 2 (MFN2) expression and decreasing Fission 1 (FIS1) expression in DKD rats studied in vivo.